All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Abstract

Synthesis, In Vitro and In Vivo antifungal activity of 5-phenylthio-2,4-bisbenzyloxypyrimidine: A novel nucleobase

Author(s): Vijayalaxmi Amareshwar1, SJ Patil2, NM Goudgaon1
1Department of Chemistry, Gulbarga University, Gulbarga-585 106, India 2Department of Zoology, Gulbarga University, Gulbarga-585 106, India

Correspondence Address:
Vijayalaxmi Amareshwar Department of Chemistry, Gulbarga University, Gulbarga-585 106 India E-mail: [email protected]


A pyrimidne nucleobase, 5-phenylthio-2,4-bisbenzyloxypyrimidine and its analogs were synthesized and scanned for in vitro antifungal activity using cup-plate and macrobroth dilution method against Candida albicans, Aspergillus niger, Aspergillus flavus and Aspergllus fumigatus. In the cup-plate method, 5-phenylthio-2,4-bisbenzyloxypyrimidine showed very good antifungal activity compared to clotrimazole at the concentrations of 100 and 1000 μg/ml and in the macrobroth dilution method, it showed comparable activity with respect to standard drugs fluconazole and itraconaole. In vivo antifungal activity of 5-phenylthio-2,4-bisbenzyloxypyrimidine at the dose levels of 10 and 30 mg/kg was carried by causing systemic infection of mice using the same fungi used in in vitro testing. The results from in vivo studies with 5-phenylthio-2,4-bisbenzyloxypyrimidine and fluconazole indicated that 5-phenylthio-2,4-bisbenzyloxypyrimidine had similar potency as fluconazole at both dose levels.



Share this